You are on page 1of 29

| 


 
  

|

R
 


 R
 


 
 !" #$%%&
Insulitis
_ R 
    
   
          
          

 ! ! "!

#$ %! ! $%!

@ 
 iabtsns
' ‰|'('()    
 !%*+


 
   
%
 +

' ,  +'(-) .  /
 0  
/
 

' , / +'(# 

  /
 


  

1 
 +

' 
" 23,4" 

 " /
 
  
" *

' ,|"5"  |,"


 
  67,4" /

   
"1*
— IRO —  ORS
?9;;@A;,,B2%"1%*;;4'|
??;A%" *;RB:|,,2‰|3|
:|4,;42>B,‰,‰'2|2

34728979:2;<2|=47>|‰;
4;,|7||';,‰42

R;;',928,4;2|929=:4;,2

2,|,;|R,;2|'|>;
;9:|,>,A
3472|',A:'|>,2
C
/  ‰
 /$A&
4 
‰

 
9 ‰


D  ‰

4
D  ‰


>35,/
/ D
 $3 


 &8,'9E/
$3

"
D 
%%&
>35,/ +
 8,'9F/ $ 

%%%&
>35" / + /,"/  8,'9E/
$9
 

%%&
 / 
/ D  0/
  / 
$2D

  &
|>;
    

|
   |>;  .
 ‰   

|"| 5*$5-))& ##*$%- &? #*$ -1&

|'# | #*$ -1%& #*$5- &1*$5-1&

| %#*$-1%& 5%*$#- &??5*$1-1&???

' ++//
/ 8?E%%%G??E%% G???
E%%%1

|
 
/ 
         
 

   
   
| 
    D  / + / 

  5%"% !!

|# %")% !!

|" %"% !!

@ 

,RR,2;|"':',;2,|'
2,|,>;'2,A:'|>,2

_ :|,,28',%"15A|42;R|
E!
_ ;,4;289|,‰'R;4||''4
E%

_ ‰|23,4|',|"5

_ |'# ||"||||'|

;2,4422;,;9;',‰|,74|
_ ;|4,‰9;R,‰;''2
A B
0 DQ8, Females 0 DQ8, Males

0.8
Proportion GADA+

0.6

0.4 0 DQ2

0.2
0 DQ2

0 10 20 30 0 10 20 30
Age at clinical onset (years)
Age at clinical onset (years)
0 10 20 30 0 10 20 30
0 DQ2
0.2
+ADAG noitroporP

0.4 0 DQ2
1 DQ2

0.6
1 DQ2

0.8
0 DQ8, Females 0 DQ8, Males
A B
A B
0 DQ8, Females 0 DQ8, Males
2 DQ2
0.8
Proportion GADA+

2 DQ2
1 DQ2
0.6

0.4 0 DQ2
1 DQ2

0.2
0 DQ2

0 10 20 30 0 10 20 30
Age at clinical onset (years)
42=R;4,A:'|>,2|2R7,;
;R|'4‰||'|'# |
,‰;''2,;'3;:,A:'|>,28

|R9|B,‰|'# | ‰|2
1,92,‰42=;R|9|

;9:|4',;|R3A|4;'B,‰
|'# | >7,;'(8
1,92‰‰442=B,‰;'(
),92‰‰442=B,‰,B;'(

'(';2;,|RR,,‰42=R;4
||'# |>:;2,315A|4;'
A B
0 DQ8, Females 0 DQ8, Males
0.8 0 DQ2 0 DQ2
Proportion IA-2A+

0.6

0.4

0.2

0.0
0 10 20 30 0 10 20 30
Age at clinical onset (years)
Age at clinical onset (years)
0 10 20 30 0 10 20 30
0.0

0.2
+A2-AI noitroporP

0.4

0.6
1 1

0.8 0 DQ2 0 DQ2

0 DQ8, Females 0 DQ8, Males


A B
A B
0 DQ8, Females 0 DQ8, Males
0.8 0 DQ2 0 DQ2
Proportion IA-2A+

1 1
0.6
2 2
0.4

0.2

0.0
0 10 20 30 0 10 20 30
Age at clinical onset (years)
42=R;4,A:'|>,2|2R7,;
;R|'4‰||'|"| 
,‰;''2R;4,A:'|>,2B,‰|"|
|, A|42;R|2,92,‰|,|,
15A|42;R|

,‰;''2R;4|‰|'',;|'()8
 ,92R;4;'()
1%,92R;4,B;'()

,‰;''2;R|‰|'',;|'(8
'4|22
%,92R;4;'(
%#,92R;4,B;'(
  

   

/
0  

/ 
 +‰|"'()
23,4

 /+
  /
42=R;4,A:'|>,2|2R7,;
;R|'4‰|23,4|'||
,‰;''2R;4,A:'|>,2B,‰||
|, A|42;R|2%,92,‰|,|,
15A|42;R|

,‰;''2R;4|‰|'',;|'()8
5,92R;4;'()
,92R;4,B;'()

,‰;''2;R|‰|'',;|23,4
|22|8
 ,92R;4;|22
,92R;4,B;|22
SURY,SO R««...
?97,:34;9,|R|,;42
?2,|,;|RR,2

?‰|‰|2,‰9|;4,RR,
" 23,4 |';,‰4,R|,;42
;,4>7,

?|"':',RR,2;R‰||';
|'# |
|| " 23,4;,4>7,2
|"|

?72R7R;49|,;R;4:4',;H
? ? ? ?


OI IO S  ?  

O IS—— 

UO-  ?  

 IODI—S 

PR—DI


YP—DI——S ?  

    

? ? 

 /+
  /
B‰|,|>;7,‰'4
|',|42H
?B|2‰,;:4',;2,7'A8
F5 %%5
 0 /
R0!
 
| / D  
 0
 /+
 
 D 
+
   D 
‰


'
 
%%
?24B>;428‰|

  
'::$R 
&,44$ 
 
&
'|2A$'D;&:|'|$
 D R&
|>2$2 
20&
' : 2$2 20&
9>;74B>;42,7'A
,A:'|>,22|,"9'|,''2|2
?:
 I
 

D/   /
,"/ 
/ D0  |'#    $:&
|"

?,  /,/'20 |'# $'


9 /
&

   // 
  
D
/ 

    "

  

?|:

  
 
/
0
++++/ 
 +
  "

  
0 C 

?,  

     +D  
   D


 +

 " / + /,/ 
 / 
 

?:


4+
+ 2/
 

 +'
 2/ B +2

 .
 
+,"/

 '
  %85!" 5%%
|'# | 
|'# 
 
 
 
` ,"/   

` '4>?%5%
  / ` |'# |   D
` |'#   
+0 
5")# / 
D
  
` |:+ "  
'4>?%5%  J/
` "
  

4 J
'
 %%
|'# | ‰||,
:42,|,;

% %  %  % %   %%% % % % % %% 


0,0
, ,0 7, 0,0
 "//
 $7 - &

, 0,0 0,
 0, 0,7
 | ' # 
  C
,0 ,

I-
 on nt@ation(U l) jD6antibo in
|,>;'A"9'|,':;,,|,;;R
|,":42,|,;

` |'# | 
 ` : D
 +

 + /+
 

  
  |'# | 

C
8
+
 0 
` : D
 + 
/ 
 
/+
  ` |//
 + 

|'# |  / /  
+
  /   0'5

'),/ 
SURY DO USIO S
?‰|‰|2,‰9|;4RR," ;,‰4,
R|,;4227‰|223,4|',|"5
;,4>7,
?97,:34;9,|R|,;42
?2,|,;|RR,2
?|4A,42:;22|4=A,;,|,;
;R>,||7,;997,A
?|"':',RR,2;R‰||';
|'# |
|| 23,4;,4>7,
|"| 
?‰4;>,|"|7,;997,A9|A>
9|,|'>A|7,;|,>;'A"R|,|,' ,
42:;22
 nol nt
` =;4|‰|9
` ‰42,|‰|9: ` ;49|>42;B
` 7;';
` ,44'|2 ` ‰|4;
` 2|‰|994 ` 4|',:;9

` 2,"|3|422; ` 2B'2‰'|>,2
` ;44|';; 42,42R;4
‰'4|'
|'7,2